Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia

Overview of attention for article published in Frontiers in Psychiatry, February 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 75 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 38 publications that cite this research output.

38

The most recent citing publications are shown below. View all 38 publications that cite this research output on Dimensions.

Molecular and micro-architectural mapping of abnormal gray matter developmental trajectories in psychosis

Preprint in medRxiv (December 2023)

Genome Sequencing of Consanguineous Family Implicates Ubiquitin-Specific Protease 53 (USP53) Variant in Psychosis/Schizophrenia: Wild-Type Expression in Murine Hippocampal CA 1–3 and Granular Dentate with AMPA Synapse Interactions

Article in Genes (October 2023)

Epigenetic regulation of metabotropic glutamate 2/3 receptors: Potential role for ultra-resistant schizophrenia?

Article in Pharmacology Biochemistry and Behavior (June 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.